Trigger warning: This article mentions abortion.
By Brendan Pierson
(February 1, 2025, REUTERS) – Trigger warning: This article mentions abortion.
A New York doctor was indicted by a grand jury in West Baton Rouge, Louisiana, on Friday for prescribing an abortion pill that was taken by a teenager there.
Margaret Carpenter and her practice, Nightingale Medical, were charged with criminal abortion by means of abortion-inducting drugs, a felony, according to an indictment provided by the West Baton Rouge District Attorney’s office. The minor’s mother was also charged.
The case appeared to be the first time a state has brought criminal charges against a doctor in another state for prescribing abortion drugs across state lines. It will likely be an early test of the power of states that criminalize abortion to prosecute providers outside their borders, and the ability of states that support abortion rights to shield providers from such prosecutions. Carpenter was also sued civilly by Texas Attorney General Ken Paxton last month.
“It is illegal to send abortion pills into this state and it’s illegal to coerce another into having an abortion,” Louisiana Attorney General Liz Murrill said in a statement. “We will hold individuals accountable for breaking the law.”
New York Governor Kathy Hochul said on Friday that the state would not comply with any request to extradite Carpenter.
New York Attorney General Letitia James in a statement said: “This cowardly attempt out of Louisiana to weaponize the law against out-of-state providers is unjust and un-American.”
Medication abortion accounts for more than half of U.S. abortions. It has drawn increasing scrutiny since the U.S. Supreme Court’s 2022 decision allowing states to ban abortion, which more than 20, including Louisiana, have done.
Louisiana last year also passed a law specifically targeting mifepristone, classifying it as a controlled substance under state law.
Mifepristone is the first part of a two-drug regimen used for medication abortion, which is approved by the FDA to terminate pregnancy in the first 10 weeks.
Carpenter, who is based in New Paltz, New York, is a co-founder of the Abortion Coalition for Telemedicine, which supports nationwide access to abortion through telemedicine.
“The case out of Louisiana against a licensed New York doctor is the latest in a series of threats that jeopardizes women’s access to reproductive healthcare throughout this country,” the Coalition said in a statement.
TEST CASES
New York is among the eight Democratic-led states that have passed so-called shield laws aiming to protect doctors who provide abortion pills to patients in other states. The law says New York will not cooperate with another state’s effort to prosecute, sue or otherwise penalize a doctor for providing the pills, as long as the doctor complies with New York law.
“These are cases designed to test New York’s shield law,” Rachel Rebouche, a professor at Temple University’s Beasley School of Law who focuses on reproductive health law, said of the Louisiana and Texas cases. She said the legal issues surrounding shield laws were “murky,” and that similar cases were likely in the future as anti-abortion prosecutors seek to test their limits.
The U.S. Constitution requires states to extradite someone who commits a crime in one state and then flees to another. It also generally requires states to respect the judgments of each other’s courts, but there are exceptions, according to Rebouche.
“This might be an issue that ends up in front of the (U.S.) Supreme Court,” Rebouche said. “What do New York courts have to do? Do they have to enforce the decisions of another state?”
In the meantime, she said, Carpenter and other doctors who help provide abortion pills face serious risk if they travel to states without shield laws.
Anti-abortion groups praised the indictment.
“Louisiana has the right and the duty to protect its citizens from high-risk abortion drugs,” said Erik Baptist, a lawyer at the conservative legal group Alliance Defending Freedom. The group until recently represented anti-abortion activists in a lawsuit seeking to restrict the availability of mifepristone nationwide, which has been taken over by Republican states after the Supreme Court ruled the original plaintiffs lacked legal standing.
Nancy Northrup, president of the pro-abortion rights Center for Reproductive Rights, in a statement said that the case is “designed to frighten other doctors from providing care to women trapped in states where abortion is banned and options are limited.”
(Reporting By Brendan Pierson and Jack Queen in New York and Tom Hals in Wilmington, Delaware; Editing by Alexia Garamfalvi, Bill Berkrot and Diane Craft)
Our Privacy Commitment
TV5 Network Inc. values and respects your privacy. We are committed to safeguarding your personal data in compliance with Republic Act No. 10173 or the Data Privacy Act of 2012 and its implementing rules and regulations.
We have developed a Privacy Policy that adopts and observes appropriate standards for personal data protection. While our Privacy Policy sets out the general principles governing the collection, use, and disclosure of our users’ personal information, our Privacy Commitment seeks to inform you more about TV5’s privacy practices.
Why do we collect your personal information (as applicable)?
We may collect and maintain basic information about you as site user of TV5 sites for the following purposes:
Where do we get your personal information?
There are several ways we collect your personal information.
Information that you personally provided.
Most of the personal information we have are those that you have provided us when you:
Information we collect during your engagement with us
We also collect information as you use our products and services, like:
Information we collect from other sources
Other means of collection of information may be through:
When do we disclose personal information?
There may be instances when we are required to share the information you provided us. In such cases, we ensure that your personal information will be disclosed on a confidential manner, through secure channels and in compliance with the Data Privacy Act and other privacy laws.
We will never share, rent, or sell your personal information to third parties outside of TV5 except in special cases where you have given consent, and in cases described in our privacy policy.
In some instances, we may be required to disclose your personal information to our agents, subsidiaries, affiliates, business partners and other third-party agencies and service providers as part of our regular business operations and for the provision of our programs and services. This means we might share your information with our service providers, contractors, and professional advisers who help us provide our services.
How we protect your personal information
The integrity, confidentiality, and security of your information is important to us. We have implemented technical, organizational, and physical security measures that are designed to protect your information from unauthorized or fraudulent access, alteration, disclosure, misuse, and other unlawful activities.
We also put in effect the following safeguards:
TV5 will not collect, use, or disclose your personal information for any purpose other than the purpose that you may have given your consent for.
What are your choices?
We make sure that we have your consent to continue to collect, use, and disclose your personal information for the purposes that we have identified. We want you to know that you may object or withdraw your consent and/or edit your consent preferences at any time.
If you wish to have access to the personal information in our custody or if you think that the personal information you provided is incomplete, or otherwise inaccurate, you may get in touch with our Data Protection Officer through the contact details provided below. In some instances, we may request for supporting documents or proof before we effect requested changes.
Data Protection Officer
TV5 Network Inc.
Reliance corner Sheridan Streets
Mandaluyong City
tv5dataprivacy@tv5.com.ph
What happens when there are changes in our Policy?
From time to time, we may update our privacy policy and practices to comply with changes in applicable laws and regulatory requirements, adapt to new technologies and protocols, and align with the best practices of the industry.
You will be provided notices if the changes are significant and, if we are required by law, we will obtain your updated consent.